April 2015

Editorial Board
Published in issue: April 2015
i

Contents
Published in issue: April 2015
v

The International Liver Congress^TM 2015. Vienna, 50th anniversary
Published in issue: April 2015
vi

Editorials

Emerging trends in hepatology: 30 years of the Journal of Hepatology and 50 years of EASL
• Rajiv Jalan
Published in issue: April 2015
S1-S3
Open Access
30 years of the Journal of Hepatology – The flagship journal and the crown-jewel of EASL
• Markus Peck-Radosavljevic
Published in issue: April 2015
S4-S5
Open Access

Reviews

Genetics of liver disease: From pathophysiology to clinical practice
• Tom H. Karlsen,
• Frank Lammert,
• Richard J. Thompson
Published in issue: April 2015
S6-S14
Open Access

Hepatic fibrosis: Concept to treatment
• Christian Trautwein,
• Scott L. Friedman,
• Detlef Schuppan,
• Massimo Pinzani
Published in issue: April 2015
S15-S24
Open Access

New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
• Ulrich Beuers,
• Michael Trauner,
• Peter Jansen,
• Raoul Poupon
Published in issue: April 2015
S25-S37
Open Access

Trends in the management and burden of alcoholic liver disease
• Philippe Mathurin,
• Ramon Bataller
Published in issue: April 2015
S38-S46
Open Access

NAFLD: A multisystem disease
• Christopher D. Byrne,
• Giovanni Targher
Published in issue: April 2015
S47-S64
Open Access

Current efforts and trends in the treatment of NASH
• Vlad Ratziu,
• Zachary Goodman,
• Arun Sanyal
Published in issue: April 2015
S65-S75
Open Access

Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
• Stephen Locarnini,
• Angelos Hatzakis,
• Ding-Shinn Chen,
• Anna Lok
Published in issue: April 2015
S76-S86
Open Access

From non-A, non-B hepatitis to hepatitis C virus cure
• Jean-Michel Pawlotsky,
• Jordan J. Feld,
• Stefan Zeuzem,
• Jay H. Hoofnagle
Published in issue: April 2015
S87-S99
Open Access

Autoimmune hepatitis – Update 2015
• Michael P. Manns,
• Ansgar W. Lohse,
• Diego Vergani
Published in issue: April 2015
S100-S111
Open Access

Acute liver failure: A curable disease by 2024?
• William Bernal,
• William M. Lee,
• Julia Wendon,
• Fin Stolze Larsen,
• Roger Williams
Published in issue: April 2015
S112-S120
Open Access

Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
• Jaume Bosch,
• Roberto J. Groszmann,
• Vijay H. Shah
Published in issue: April 2015
S121-S130
Open Access

Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis
• Vicente Arroyo,
• Richard Moreau,
• Rajiv Jalan,
• Pere Ginès
• On behalf of the investigators of the EASL-CLIF Consortium CANONIC Study
Published in issue: April 2015
S131-S143
Open Access

Liver cancer: Approaching a personalized care
• Jordi Bruix,
• Kwang-Hyub Han,
• Gregory Gores,
• Josep Maria Llovet,
• Vincenzo Mazzaferro
Published in issue: April 2015
S144-S156
Open Access

Cell therapy for liver disease: From liver transplantation to cell factory
• Stuart J. Forbes,
• Sanjeev Gupta,
• Anil Dhawan
Published in issue: April 2015
S157-S169
Open Access

From immunosuppression to tolerance
• David H. Adams,
• Alberto Sanchez-Fueyo,
• Didier Samuel
Published in issue: April 2015
S170-S185
Open Access
EASL Monothematic Conference, Liver Disease in Resource Limited Settings. Bucharest, Romania, 2015
Published in issue: April 2015
S186
Join EASL. Take an active role in the most forward thinking and dynamic hepatology community worldwide
Published in issue: April 2015
IBC

Frontmatter

The International Liver Congress^TM 2016. Barcelona, Spain
Published in issue: April 2015
IFC